Purulent pericarditis

Article written and reviewed by Dr Luca Moretti

The purulent pericarditis is a suppurative infection of the pericardial sac characterized by accumulation of exudate rich in neutrophils, debris, and microorganisms. It is an infectious disease and cardiologic emergency because the collection can impair filling, sustain sepsis, and rapidly organize into compartments that are difficult to drain. Its severity does not depend solely on the presence of tamponade: infected material must be controlled even when blood pressure is initially preserved.

Most cases are caused by pyogenic bacteria, but the term purulent describes the pathologic appearance, whereas bacterial pericarditis defines a broader etiologic category. In selected patients, other microorganisms and mixed infections can produce suppurative collections. A negative culture after antibiotics does not exclude the diagnosis when the material and clinical context are convincing. Conversely, echocardiographic fibrin or turbid fluid alone does not necessarily identify an infection and requires appropriate analysis.

Management integrates three goals: decompress the heart when necessary, eradicate the pericardial focus, and treat the pathogen together with the source from which it originates. Initial control does not complete management, because thick pus, septa, and adhesions may leave residual pockets and promote constriction. The choice among catheter drainage, surgical drainage, and intrapericardial treatments must therefore be reassessed according to anatomic, microbiologic, and hemodynamic response.

Etiology, sources, and organization of the exudate

The staphylococci, especially Staphylococcus aureus, are important in hematogenous infections and those associated with procedures or healthcare exposure. Streptococci, including pneumococcus, may be involved in spread from respiratory infections or other foci. Gram-negative bacilli, anaerobes, and polymicrobial combinations become more relevant according to source and host conditions. Identification cannot be predicted with certainty from the appearance of pus, and initial therapy must consider local epidemiology and resistance risk before being narrowed according to results.

The contiguous thoracic spread is an important route. Complicated pneumonia, empyema, and mediastinitis may extend to the pericardium; esophageal perforations or fistulas create scenarios in which contamination continues until the lesion is corrected. Cardiac surgery and trauma may directly introduce microorganisms or predispose to collections that subsequently become infected. Pericardial infection may therefore represent only part of the pathologic anatomy that must be treated, and drainage of a single compartment does not guarantee control of the entire process.

The bacteremia arising from vascular access sites, skin, deep tissues, or endocarditis may seed the pericardial sac. Concordance among specimens helps reconstruct the route, but the origin is not always demonstrable. Infected devices, metastatic collections, and valvular disease should be investigated when suggested by the organism or by persistent positive cultures. An apparently small distant focus may maintain the infection, whereas local resolution of the effusion does not exclude a still-active hematogenous source.

The suppurative injury arises from the neutrophilic response and tissue destruction. Cellular enzymes, microbial products, and mediators increase permeability and promote accumulation of viscous material. Glucose consumption and intense inflammatory activity alter fluid biochemistry but do not provide etiologic identification. Suppuration may be macroscopically evident or partially modified by previously administered antibiotics. A sample obtained after treatment must be interpreted in light of this change, not only by the final culture result.

Deposition of fibrin creates a network in which cells and debris accumulate, producing loculations. The cavity loses its functional continuity: a drain may be well positioned in one pocket yet ineffective for others. Subsequently fibroblasts and collagen make the tissue less reversible and create the substrate for constriction. Fibrinolysis acts on the fibrin component, does not dissolve a mature collagenous peel, and does not sterilize the compartment; this biologic limitation is essential for understanding its indications.

The predisposing factors include immunosuppression, chronic diseases, malignancies, renal failure, and recent procedures. These conditions may make the presentation less typical and increase the risk of resistant pathogens or concomitant infections. In immunocompromised patients, fungal or mycobacterial causes should also be considered when the clinical picture warrants it. The rarity of the disease should not reduce vigilance when sepsis and a pericardial collection coexist, particularly in the presence of a plausible anatomic source.

Pathophysiology of tamponade, sepsis, and constriction

The purulent collection can increase intrapericardial pressure and reduce the gradient that permits cardiac filling. Hemodynamic compromise depends on the rate of accumulation, distensibility, and distribution rather than on a single volume threshold. Septa may cause regional compression and make the signs of circumferential tamponade less recognizable. A posterior or postoperative pocket may therefore be clinically important even when an echocardiographic window shows only a small anterior layer.

The reduction in cardiac output stimulates tachycardia and vasoconstriction, but sepsis may add vasodilation and alter the overall picture. Elevated venous pressure and low arterial pressure may result from a combination of obstruction, myocardial depression, and distributive physiology. Support with fluids or vasopressors does not remove the external constraint. Decompression, in turn, may improve output without correcting major vasoplegia. Reassessment after the procedure is therefore necessary to identify which mechanism continues to compromise perfusion.

The positive-pressure ventilation can reduce venous return and precipitate instability in a preload-dependent patient. Sedation and anesthetic induction require expert planning when significant compression is present. This does not mean withholding essential respiratory support, but rather coordinating decompression, anesthesia, and hemodynamic management. The possibility of deterioration during transfer or a procedure makes it important to choose a setting with appropriate personnel and equipment, without relying on blood-pressure stability observed only minutes earlier.

The systemic sepsis may impair the microcirculation and the function of the kidneys, liver, lungs, and nervous system. Lactate, urine output, mental status, and peripheral perfusion describe complementary aspects without being specific to the pericardium. A fall in lactate after treatment is favorable but does not prove that all loculations have been evacuated. Elevated troponin and ventricular dysfunction must also be interpreted in context, distinguishing septic myocardial injury, supply-demand ischemia, and direct cardiac involvement.

The effusive-constrictive physiology may become apparent after fluid evacuation. An inflamed or organized visceral layer continues to limit expansion, maintaining elevated filling pressures. Before attributing the finding to constriction, residual compressive pockets and other causes of elevated right-sided pressure must be excluded. Echocardiography with respiratory analysis and Doppler helps identify the mechanism; in unresolved cases, further testing is selected once the patient is stabilized.

The late constriction arises from fibroadhesive organization and may persist after the infection has healed. This risk makes early control of the collection important, without guaranteeing that every intervention will completely prevent remodeling. Ongoing inflammation may contribute to a reversible constraint, whereas mature fibrosis requires surgical consideration. Monitoring only fever and cultures would miss the mechanical component of the disease, which must be assessed through congestion, functional capacity, and filling physiology.

Clinical manifestations and urgent diagnosis

The presentation is often that of a severe febrile illness, with sepsis or rapid deterioration in a patient already hospitalized for another infection. Chest pain, friction rub, and ECG changes may be absent or masked. In sedated patients, young children, or immunocompromised individuals, dyspnea and instability may be the first recognizable signs. A new effusion during bacteremia or thoracic infection requires causal assessment, without assuming that it is always a sterile reaction.

The assessment for tamponade considers tachycardia, hypotension, jugular venous distention, pulsus paradoxus, and hypoperfusion, but does not require all signs to be present simultaneously. A loculated process may not show classic physiology. Urgent echocardiography evaluates distribution, compression, ventricular function, and the vena cava, integrating flow variations. The absence of right-sided chamber collapse in the presence of high intracardiac pressures does not exclude every form of compression; the result must be interpreted in the specific clinical setting.

Findings that should prompt consideration of a purulent collection

• Sepsis or documented bacterial infection with a new, complex, or enlarging pericardial effusion.
• Pus in the pericardial sample, marked neutrophilic exudate, or demonstration of relevant microorganisms.
• Contiguous thoracic focus, mediastinitis, recent procedure, or bacteremia with an uncontrolled course.
• Instability or persistent inflammatory response not explained by the known infection alone.

The list guides clinical suspicion and does not replace an integrated diagnosis. According to ESC recommendations, suspected purulent pericarditis warrants diagnostic and therapeutic drainage regardless of hemodynamic status. It is therefore inappropriate to wait for tamponade before intervening on a collection that is likely infected. In an unstable patient, specimen collection, antimicrobials, and the procedure should proceed in a coordinated manner, avoiding delays caused by pursuing impossible preliminary certainty.

The chest CT defines loculations, mediastinal extension, empyema, and sources that echocardiography does not fully characterize. It is particularly useful in postoperative patients or when a pathologic communication is suspected. It should not, however, necessarily precede decompression of obvious tamponade. Cardiac magnetic resonance has a later role in assessing tissue involvement and constriction but is not the priority examination for deciding urgent drainage of pus.

The blood tests include complete blood count, inflammatory markers, organ function, electrolytes, and lactate in severe cases, together with blood cultures. ECG and troponin contribute to assessment of cardiac complications. No biomarker can exclude a suppurative collection when the context is convincing. The differential diagnosis includes hemopericardium, neoplastic effusions, tuberculosis, and noninfected postoperative collections, but the differential workup must not delay control of a highly likely source in a deteriorating patient.

Microbiology, source investigation, and assessment of drainage

Pericardial material must be collected and handled as a specimen from a sterile site, using methods that preserve its diagnostic value. Direct staining, aerobic and anaerobic cultures, and susceptibility testing are central. The laboratory should be informed of prior antibiotics, immunosuppression, and specific suspicions. When indicated, mycobacterial, fungal, or molecular testing is added; it is incorrect to assume that a single container or routine culture can answer every microbiologic question.

The negative culture may result from prior therapy, low organism viability, inadequate transport, or fastidious pathogens. In the presence of gross pus and a coherent clinical picture, it does not negate the diagnosis. Molecular techniques on suitable material may increase yield in selected cases but require interpretation and do not always replace susceptibility data. A sample obtained from a drain that has remained in place for a long time may instead reflect colonization; its significance differs from that of an initial direct specimen.

The concordance among specimens helps link the pericardium to the source. Blood cultures, pleural material, surgical tissues, and other samples should be compared with attention to timing and treatment. A single skin isolate requires caution, whereas repeated growth and coherence with devices or procedures may support pathogenic relevance. If bacteremia persists, endocarditis, access-site infection, and deep foci should be investigated according to the organism and clinical picture. The pericardium may be the source, a secondary site, or both during the episode.

The source anatomy determines the risk of failure. An undrained empyema, mediastinitis, or fistula may continue to contaminate the compartment despite active antibiotics. Surgical assessment should therefore include the underlying source problem, not only tube placement. CT and intraoperative findings help identify routes of spread and material not reached by drainage. Success is judged by coordinated resolution of the different collections and by microbiologic control when measurable.

The drain function must be monitored through output, patency, and imaging. A sudden decrease in volume may mean successful evacuation, but it may also indicate obstruction by thick material, displacement, or isolation within an emptied compartment. Manipulations and flushing follow specialist protocols, avoiding uncontrolled pressures or maneuvers. Persistent fever, sepsis, or significant collections require prompt revision of the strategy. Recording a daily volume is insufficient unless it is confirmed to represent the entire infected cavity.

The assessment after decompression documents ventricular function, venous pressures, and signs of constriction. Incomplete recovery may reflect residual sepsis, myocardial dysfunction, visceral constraint, or unevacuated fluid. Distinguishing these mechanisms avoids unnecessarily prolonging an ineffective drain or interpreting all congestion as a need for further aspiration. Clinical, microbiologic, and anatomic evolution must be considered together, with explicit criteria for escalating to a more invasive approach when necessary.

Antibiotics, intensive support, and response goals

The antimicrobial therapy is started promptly intravenously, after timely specimens are obtained when this can be done without dangerous delay. In shock or highly probable sepsis, waiting for definitive confirmation is inappropriate. The initial regimen must cover plausible organisms according to source, recent healthcare exposure, immune status, and local resistance patterns. The label purulent does not identify a single combination: a community-acquired collection associated with pneumonia and a postoperative mediastinitis require different assessments.

The antistaphylococcal coverage is especially relevant in hematogenous infections, after procedures, and when there is a risk of methicillin resistance. Vancomycin or appropriate alternatives are selected according to expected susceptibility, renal function, and infection characteristics. A beta-lactam may complete coverage of streptococci and Gram-negative organisms depending on context; cephalosporins, piperacillin-tazobactam, and carbapenems address different needs. Suspected esophageal or polymicrobial sources may require anaerobic activity. Empirical addition of antifungal therapy is not universal and depends on specific risk factors.

After identification, de-escalation selects the most targeted regimen that maintains efficacy. For some isolates, such as methicillin-susceptible staphylococci, an appropriate beta-lactam may be preferable to automatically continuing coverage for resistant organisms. Dosing must account for sepsis-related pharmacokinetic changes and organ function, with drug-level monitoring when relevant. A favorable susceptibility report alone does not guarantee adequate exposure or useful penetration into a compartmentalized cavity that has not been drained.

The duration of antibiotic therapy is individualized. The 2025 ESC guidelines indicate at least three weeks for purulent pericarditis, with continuation according to resolution of fever and clinical signs; associated foci and complications may require longer treatment. The date of drainage, clearance of bacteremia, and presence of residual material all contribute to the decision. Improvement in inflammatory markers is useful but does not justify stopping therapy if an anatomic source persists. The final decision requires shared clinical judgment rather than an automatic deadline.

The support for shock is adapted to the mixed mechanism. The 2026 sepsis guidelines call for early treatment and source control, but the presence of tamponade requires even more immediate correction of the obstruction. Crystalloids and vasopressors are titrated with reassessment of perfusion and congestion; norepinephrine is a standard initial vasopressor in septic shock. Indiscriminate fluid loading does not resolve compression and may worsen congestion or respiratory failure. Ventilatory needs are coordinated with the decompression strategy.

The anti-inflammatory drugs may have a selective symptomatic role but are not the therapy that controls this disease. Colchicine and interleukin-1-targeted drugs do not replace antibiotics and drainage and should not be transferred automatically from idiopathic recurrence protocols. Corticosteroids may be indicated for specific intensive-care conditions, such as some forms of persistent shock, but this is different from attempting to treat suppuration with immunosuppression. Renal function, bleeding, and gastrointestinal risk also limit NSAID use in critically ill patients.

The response goals include stabilization of perfusion, reduction of fever, microbiologic clearance when measurable, evacuation of collections, and organ recovery. If one of these domains fails to improve, the reason should be sought rather than nonspecifically intensifying therapy. Daily assessment should include drain patency and the possibility of an extracardiac focus. Early involvement of a cardiologist, infectious disease specialist, intensivist, and surgeon makes it possible to correct an inadequate strategy promptly.

Surgical drainage, intrapericardial fibrinolysis, and failure of source control

The immediate drainage has priority when the collection compromises filling. Image-guided pericardiocentesis can rapidly decompress the heart and provide material, but it must be followed by an effective evacuation strategy. Very thick pus, numerous septa, and localized collections may make a small catheter insufficient. The initial choice takes anatomy, circulatory status, and surgical availability into account, without reducing the problem to an absolute opposition between percutaneous and surgical techniques.

The surgical access permits wider drainage, irrigation, specimen collection, and opening of selected loculations. A subxiphoid pericardiotomy or other approaches are chosen according to distribution and source. In postoperative settings or mediastinitis, infected tissues and adjacent collections may need to be treated at the same time. Operative risk must be balanced against the risk of leaving uncontrolled pus; waiting for repeated percutaneous failures when anatomy is clearly unfavorable may worsen the course.

The intrapericardial fibrinolysis aims to disrupt fibrinous septa and facilitate evacuation. The 2025 ESC guidelines state that it should be considered in purulent pericarditis to promote complete drainage and prevent constriction. The rationale does not amount to proof that every patient benefits or that it can replace surgery. Literature reviews include heterogeneous case series with different organisms, protocols, and populations; the level of certainty must remain distinct from the strength of a clinical recommendation.

Treatment requires selection and monitoring. The position and patency of the access, characteristics of the collections, bleeding risk, recent procedures, and possibility of active bleeding must be assessed. Agent, dose, dilution, dwell time, and any repeat administrations depend on specialist protocols and lack a single universally validated standard. The procedure should not be improvised on the basis of doses used in other body compartments. Risks include bleeding, drug reactions, and pressure increase if instilled fluid cannot be adequately evacuated.

The biologic limitation is the distinction between recent fibrin and mature fibrous organization. A pocket crossed by fibrinous septa may be more amenable to treatment than an adherent collagen-rich peel. Fibrinolysis does not sterilize the space or correct a fistula or extracardiac focus. Response must be verified through output and imaging, without indefinitely prolonging attempts that do not change sepsis or anatomy. Persistent instability requires immediate reassessment of the access and the need for surgery.

The failure of source control is recognized by persistence or recurrence of sepsis, bacteremia, infected material, and undrained collections, not merely by the number of days elapsed. Drain revision, debridement, or a more extensive procedure may be necessary. Pericardiectomy is reserved for selected situations, including infection that cannot be controlled with less extensive approaches or persistent constriction; it is not mandatory in every acute phase. The extent of resection must account for adhesions, cardiac structures, and bleeding risk.

The completion of drainage requires concordance among the clinical course, characteristics of the output, and absence of significant reachable collections. An isolated volume threshold is insufficient when the tube may be obstructed. After removal, surveillance checks for reaccumulation and signs of constriction. Technical success of the procedure must be distinguished from overall cure, which includes source control, completed antimicrobial treatment, and sustained hemodynamic recovery.

Prognosis, complications, and recovery after infection

The prognosis is influenced by timeliness of treatment and the ability to achieve complete anatomic source control. Without treatment the disease has extremely high mortality; with antibiotics and drainage outcomes improve, but remain influenced by shock, age, immune status, and associated foci. Percentages from historical series should not be presented as an individual contemporary prediction. The rarity of the disease and case selection make it difficult to separate the effect of a single procedure from the severity of the patients who receive it.

Early complications include multiorgan failure, arrhythmias, myocardial dysfunction, bleeding, and persistent tamponade. After evacuation, deterioration requires consideration of procedural complications and loading changes, in addition to residual sepsis and undrained pockets. Intensive support must adapt to the evolving situation rather than being maintained solely on the basis of the initial presentation. A favorable blood-pressure response does not exclude ongoing infection, just as falling fever does not exclude persistent compression.

The infectious recurrence may occur if loculations, contaminated material, or extracardiac sources remain. New specimens are required when appropriate and should be compared with the initial isolates, distinguishing persistence of the same organism from a new infection. Devices and access sites used during treatment can themselves become sources. Microbiologic interpretation should avoid both indiscriminate broadening of therapy and the incorrect conclusion that every late positive culture is irrelevant.

The constriction is one of the major long-term concerns. Exertional dyspnea, edema, ascites, and persistently elevated venous pressure require functional reassessment even after infectious markers normalize. Echocardiography looks for respiratory interdependence and flow abnormalities, whereas CT and cardiac magnetic resonance define anatomy and residual activity. An inflammatory constraint may improve, but fibrosis with refractory congestion requires evaluation for pericardiectomy. Waiting must be limited by the risk of progressive hepatic, renal, and nutritional injury.

The consequences of hospitalization include deconditioning, loss of muscle mass, disability, and drug toxicity. Recovery requires nutrition, mobilization, and surveillance proportionate to the cardiac condition. Renal function, complete blood count, and other monitoring are scheduled according to the antimicrobial regimen and duration. When therapy continues after discharge, responsibilities, access to follow-up, and warning signs requiring urgent reassessment must be clear.

The cardiology follow-up assesses effusion, physiology, and functional capacity, while infectious disease follow-up confirms adequacy and completion of therapy. Frequency is individualized according to initial severity and residual findings. New fever, increasing dyspnea, or congestion should not be interpreted as normal consequences of convalescence without investigation. The final goal is recovery that includes absence of an active focus, hemodynamic stability, and return to daily life, while separately recognizing any permanent pericardial sequelae.

References
1. Schulz-Menger J et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. European Heart Journal. 2025;46(40):3952-4041.
2. Klein AL et al. Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging. JACC: Cardiovascular Imaging. 2024;17(8):937-988.
3. Adler Y et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2015;36(42):2921-2964.
4. Pankuweit S et al. Bacterial pericarditis: diagnosis and management. American Journal of Cardiovascular Drugs. 2005;5(2):103-112.
5. Sagristà-Sauleda J et al. Purulent pericarditis: review of a 20-year experience in a general hospital. Journal of the American College of Cardiology. 1993;22(6):1661-1665.
6. Roberts WC. Pericardial heart disease: its morphologic features and its causes. Proceedings (Baylor University Medical Center). 2005;18(1):38-55.
7. Augustin P et al. Clinical review: intrapericardial fibrinolysis in management of purulent pericarditis. Critical Care. 2011;15(2):220.
8. Wiyeh AB et al. A systematic review of the efficacy and safety of intrapericardial fibrinolysis in patients with pericardial effusion. International Journal of Cardiology. 2018;250:223-228.
9. Society of Critical Care Medicine; European Society of Intensive Care Medicine. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Society of Critical Care Medicine. 2026. Online recommendations. Accessed September 26, 2026. https://www.sccm.org/clinical-resources/guidelines/guidelines/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and-septic-shock-2026.
10. Spodick DH. Acute cardiac tamponade. New England Journal of Medicine. 2003;349(7):684-690.
11. Imazio M et al. Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011;124(11):1270-1275.
12. Sagristà-Sauleda J et al. Effusive-constrictive pericarditis. New England Journal of Medicine. 2004;350(5):469-475.